Chief Medical Officer (CMO) ADCs / Bispecifics/ Oncology
Hybrid
San Francisco/Bay Area, CA
Job Description
A high-growth VC-backed biotech specializing in Antibody Drug Conjugates (ADCs) is seeking a Chief Medical Officer (CMO) to lead clinical and regulatory strategy, driving the development of cutting-edge therapies from IND through regulatory approval.
This is a unique opportunity for a clinical development leader to shape the success of a pioneering biotech at the forefront ADCs in cancer therapeutics.
Key Responsibilities
- Define and oversee the clinical development strategy for a first-in-class pipeline.
- Lead IND, CTA, and regulatory filings, engaging with FDA, EMA, and global health authorities.
- Direct Phase I-III clinical trials, ensuring scientific and operational excellence.
- Collaborate with R&D and translational medicine teams to optimize biomarker-driven trial design.
- Represent the company at scientific conferences, investor meetings, and key industry events.
- Partner with BD and Commercial teams on strategic partnerships and future market planning.
Candidate Profile
- MD (or MD/PhD) with 10+ years of experience in clinical development.
- Extensive experience in Oncology drug development, including Bispecifcs, T-Cell Engagers, Immune Modulators
- Proven track record of advancing oncology assets from early-phase trials through regulatory approval.
- Strong experience in regulatory interactions (FDA, EMA) and global trial execution.
- Ability to thrive in a VC-backed, high-growth biotech environment.
Qualified candidates should send CV and cover letter to jobs@tseworldwide.com